<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
----------------------------------
FORM 8-A
FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES
PURSUANT TO SECTION 12(b) OR 12(g) OF THE
SECURITIES EXCHANGE ACT OF 1934
TRANSKARYOTIC THERAPIES, INC.
------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Delaware 04-3027191
- ----------------------- -------------------
(State of Incorporation (IRS Employer
or Organization) Identification No.)
195 Albany Street
Cambridge, Massachusetts 02139
- ---------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
Securities to be registered pursuant to Section 12(b) of the Act:
None.
Securities to be registered pursuant to Section 12(g) of the Act:
Common Stock, par value $.01
----------------------------
(Title of Class)
<PAGE> 2
Item 1. Description of Registrant's Securities to be Registered.
--------------------------------------------------------
The description of the Registrant's Common Stock, $.01 par value per
share, appearing under the caption "Description of Capital Stock" in the
Prospectus included as a part of the Registrant's Registration Statement on Form
S-1, File No. 333-10845, filed with the Securities and Exchange Commission on
August 27, 1996 (the "Registration Statement on Form S-1") is incorporated
herein by reference.
Item 2. Exhibits.
---------
The following exhibits are filed herewith (or incorporated by reference as
indicated below):
1. Amended and Restated Certificate of Incorporation of the Registrant
(incorporated by reference to Exhibit 3.1 to the Registration
Statement on Form S-1).
2. Form of Amended and Restated Certificate of Incorporation of the
Registrant (incorporated by reference to Exhibit 3.2 to the
Registration Statement on Form S-1).
3. By-Laws of the Registrant (incorporated by reference to Exhibit 3.3
to the Registration Statement on Form S-1).
4. Form of Amended and Restated By-Laws of the Registrant (incorporated
by reference to Exhibit 3.4 to the Registration Statement on Form
S-1).
5. Proposed stock certificate for the securities registered hereunder
(incorporated by reference to Exhibit 4.1 to the Registration
Statement on Form S-1).
- 2 -
<PAGE> 3
SIGNATURE
Pursuant to the requirements of Section 12 of the Securities Exchange Act
of 1934, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereto duly authorized.
TRANSKARYOTIC THERAPIES, INC.
Date: September 30, 1996 By: /s/ Richard F Selden
-------------------------------
Richard F Selden
President and
Chief Executive Officer
- 3 -
